A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study

NCT07751497 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Vestibular Migraine

Interventions

DRUG: Rimegepant
DRUG: Flunarizine

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine